0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Benign Prostatic Hyperplasic Device Market Research Report 2022
Published Date: August 2022
|
Report Code: QYRE-Auto-3C11689
Home | Market Reports | Health| Men s Health
Global Benign Prostatic Hyperplasic Device Market Research Report 2022
BUY CHAPTERS

Global Benign Prostatic Hyperplasic Device Market Research Report 2022

Code: QYRE-Auto-3C11689
Report
August 2022
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Highlights

The global Benign Prostatic Hyperplasic Device market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.

North American market for Benign Prostatic Hyperplasic Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

Asia-Pacific market for Benign Prostatic Hyperplasic Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

The major global manufacturers of Benign Prostatic Hyperplasic Device include KARL STORZ SE, Richard Wolf GmbH, Olympus Corporation, Urologix, Boston Scientific Corporation, Butterfly, TELEFLEX Incorporated, OmniGuide Holdings and Convergent Laser Technologies, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.

The global market for Benign Prostatic Hyperplasic Device in Hospitals is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Radiofrequency Ablation Devices, which accounted for % of the global market of Benign Prostatic Hyperplasic Device in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Benign Prostatic Hyperplasic Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Benign Prostatic Hyperplasic Device.
The Benign Prostatic Hyperplasic Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Benign Prostatic Hyperplasic Device market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Benign Prostatic Hyperplasic Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
KARL STORZ SE
Richard Wolf GmbH
Olympus Corporation
Urologix
Boston Scientific Corporation
Butterfly
TELEFLEX Incorporated
OmniGuide Holdings
Convergent Laser Technologies
ProArc
Olympus Corporation
Product Type Insights
Global markets are presented by Benign Prostatic Hyperplasic Device type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Benign Prostatic Hyperplasic Device are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Benign Prostatic Hyperplasic Device segment by Type

Radiofrequency Ablation Devices
Urology Lasers Devices
Others
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Benign Prostatic Hyperplasic Device market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Benign Prostatic Hyperplasic Device market.

Benign Prostatic Hyperplasic Device segment by Application

Hospitals
Clinics
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Benign Prostatic Hyperplasic Device market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Benign Prostatic Hyperplasic Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Benign Prostatic Hyperplasic Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Benign Prostatic Hyperplasic Device industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Benign Prostatic Hyperplasic Device.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Benign Prostatic Hyperplasic Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Benign Prostatic Hyperplasic Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
1 Benign Prostatic Hyperplasic Device Market Overview
1.1 Product Overview and Scope of Benign Prostatic Hyperplasic Device
1.2 Benign Prostatic Hyperplasic Device Segment by Type
1.2.1 Global Benign Prostatic Hyperplasic Device Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Radiofrequency Ablation Devices
1.2.3 Urology Lasers Devices
1.2.4 Others
1.3 Benign Prostatic Hyperplasic Device Segment by Application
1.3.1 Global Benign Prostatic Hyperplasic Device Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Benign Prostatic Hyperplasic Device Market Size Estimates and Forecasts
1.4.1 Global Benign Prostatic Hyperplasic Device Revenue 2017-2028
1.4.2 Global Benign Prostatic Hyperplasic Device Sales 2017-2028
1.4.3 Benign Prostatic Hyperplasic Device Market Size by Region: 2017 Versus 2021 Versus 2028
2 Benign Prostatic Hyperplasic Device Market Competition by Manufacturers
2.1 Global Benign Prostatic Hyperplasic Device Sales Market Share by Manufacturers (2017-2022)
2.2 Global Benign Prostatic Hyperplasic Device Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Benign Prostatic Hyperplasic Device Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Benign Prostatic Hyperplasic Device Manufacturing Sites, Area Served, Product Type
2.5 Benign Prostatic Hyperplasic Device Market Competitive Situation and Trends
2.5.1 Benign Prostatic Hyperplasic Device Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Benign Prostatic Hyperplasic Device Players Market Share by Revenue
2.5.3 Global Benign Prostatic Hyperplasic Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Benign Prostatic Hyperplasic Device Retrospective Market Scenario by Region
3.1 Global Benign Prostatic Hyperplasic Device Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Benign Prostatic Hyperplasic Device Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Benign Prostatic Hyperplasic Device Market Facts & Figures by Country
3.3.1 North America Benign Prostatic Hyperplasic Device Sales by Country
3.3.2 North America Benign Prostatic Hyperplasic Device Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Benign Prostatic Hyperplasic Device Market Facts & Figures by Country
3.4.1 Europe Benign Prostatic Hyperplasic Device Sales by Country
3.4.2 Europe Benign Prostatic Hyperplasic Device Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Benign Prostatic Hyperplasic Device Market Facts & Figures by Region
3.5.1 Asia Pacific Benign Prostatic Hyperplasic Device Sales by Region
3.5.2 Asia Pacific Benign Prostatic Hyperplasic Device Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Benign Prostatic Hyperplasic Device Market Facts & Figures by Country
3.6.1 Latin America Benign Prostatic Hyperplasic Device Sales by Country
3.6.2 Latin America Benign Prostatic Hyperplasic Device Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Benign Prostatic Hyperplasic Device Market Facts & Figures by Country
3.7.1 Middle East and Africa Benign Prostatic Hyperplasic Device Sales by Country
3.7.2 Middle East and Africa Benign Prostatic Hyperplasic Device Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Benign Prostatic Hyperplasic Device Historic Market Analysis by Type
4.1 Global Benign Prostatic Hyperplasic Device Sales Market Share by Type (2017-2022)
4.2 Global Benign Prostatic Hyperplasic Device Revenue Market Share by Type (2017-2022)
4.3 Global Benign Prostatic Hyperplasic Device Price by Type (2017-2022)
5 Global Benign Prostatic Hyperplasic Device Historic Market Analysis by Application
5.1 Global Benign Prostatic Hyperplasic Device Sales Market Share by Application (2017-2022)
5.2 Global Benign Prostatic Hyperplasic Device Revenue Market Share by Application (2017-2022)
5.3 Global Benign Prostatic Hyperplasic Device Price by Application (2017-2022)
6 Key Companies Profiled
6.1 KARL STORZ SE
6.1.1 KARL STORZ SE Corporation Information
6.1.2 KARL STORZ SE Description and Business Overview
6.1.3 KARL STORZ SE Benign Prostatic Hyperplasic Device Sales, Revenue and Gross Margin (2017-2022)
6.1.4 KARL STORZ SE Benign Prostatic Hyperplasic Device Product Portfolio
6.1.5 KARL STORZ SE Recent Developments/Updates
6.2 Richard Wolf GmbH
6.2.1 Richard Wolf GmbH Corporation Information
6.2.2 Richard Wolf GmbH Description and Business Overview
6.2.3 Richard Wolf GmbH Benign Prostatic Hyperplasic Device Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Richard Wolf GmbH Benign Prostatic Hyperplasic Device Product Portfolio
6.2.5 Richard Wolf GmbH Recent Developments/Updates
6.3 Olympus Corporation
6.3.1 Olympus Corporation Corporation Information
6.3.2 Olympus Corporation Description and Business Overview
6.3.3 Olympus Corporation Benign Prostatic Hyperplasic Device Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Olympus Corporation Benign Prostatic Hyperplasic Device Product Portfolio
6.3.5 Olympus Corporation Recent Developments/Updates
6.4 Urologix
6.4.1 Urologix Corporation Information
6.4.2 Urologix Description and Business Overview
6.4.3 Urologix Benign Prostatic Hyperplasic Device Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Urologix Benign Prostatic Hyperplasic Device Product Portfolio
6.4.5 Urologix Recent Developments/Updates
6.5 Boston Scientific Corporation
6.5.1 Boston Scientific Corporation Corporation Information
6.5.2 Boston Scientific Corporation Description and Business Overview
6.5.3 Boston Scientific Corporation Benign Prostatic Hyperplasic Device Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Boston Scientific Corporation Benign Prostatic Hyperplasic Device Product Portfolio
6.5.5 Boston Scientific Corporation Recent Developments/Updates
6.6 Butterfly
6.6.1 Butterfly Corporation Information
6.6.2 Butterfly Description and Business Overview
6.6.3 Butterfly Benign Prostatic Hyperplasic Device Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Butterfly Benign Prostatic Hyperplasic Device Product Portfolio
6.6.5 Butterfly Recent Developments/Updates
6.7 TELEFLEX Incorporated
6.6.1 TELEFLEX Incorporated Corporation Information
6.6.2 TELEFLEX Incorporated Description and Business Overview
6.6.3 TELEFLEX Incorporated Benign Prostatic Hyperplasic Device Sales, Revenue and Gross Margin (2017-2022)
6.4.4 TELEFLEX Incorporated Benign Prostatic Hyperplasic Device Product Portfolio
6.7.5 TELEFLEX Incorporated Recent Developments/Updates
6.8 OmniGuide Holdings
6.8.1 OmniGuide Holdings Corporation Information
6.8.2 OmniGuide Holdings Description and Business Overview
6.8.3 OmniGuide Holdings Benign Prostatic Hyperplasic Device Sales, Revenue and Gross Margin (2017-2022)
6.8.4 OmniGuide Holdings Benign Prostatic Hyperplasic Device Product Portfolio
6.8.5 OmniGuide Holdings Recent Developments/Updates
6.9 Convergent Laser Technologies
6.9.1 Convergent Laser Technologies Corporation Information
6.9.2 Convergent Laser Technologies Description and Business Overview
6.9.3 Convergent Laser Technologies Benign Prostatic Hyperplasic Device Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Convergent Laser Technologies Benign Prostatic Hyperplasic Device Product Portfolio
6.9.5 Convergent Laser Technologies Recent Developments/Updates
6.10 ProArc
6.10.1 ProArc Corporation Information
6.10.2 ProArc Description and Business Overview
6.10.3 ProArc Benign Prostatic Hyperplasic Device Sales, Revenue and Gross Margin (2017-2022)
6.10.4 ProArc Benign Prostatic Hyperplasic Device Product Portfolio
6.10.5 ProArc Recent Developments/Updates
6.11 Olympus Corporation
6.11.1 Olympus Corporation Corporation Information
6.11.2 Olympus Corporation Benign Prostatic Hyperplasic Device Description and Business Overview
6.11.3 Olympus Corporation Benign Prostatic Hyperplasic Device Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Olympus Corporation Benign Prostatic Hyperplasic Device Product Portfolio
6.11.5 Olympus Corporation Recent Developments/Updates
7 Benign Prostatic Hyperplasic Device Manufacturing Cost Analysis
7.1 Benign Prostatic Hyperplasic Device Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasic Device
7.4 Benign Prostatic Hyperplasic Device Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Benign Prostatic Hyperplasic Device Distributors List
8.3 Benign Prostatic Hyperplasic Device Customers
9 Benign Prostatic Hyperplasic Device Market Dynamics
9.1 Benign Prostatic Hyperplasic Device Industry Trends
9.2 Benign Prostatic Hyperplasic Device Market Drivers
9.3 Benign Prostatic Hyperplasic Device Market Challenges
9.4 Benign Prostatic Hyperplasic Device Market Restraints
10 Global Market Forecast
10.1 Benign Prostatic Hyperplasic Device Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Benign Prostatic Hyperplasic Device by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Benign Prostatic Hyperplasic Device by Type (2023-2028)
10.2 Benign Prostatic Hyperplasic Device Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Benign Prostatic Hyperplasic Device by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Benign Prostatic Hyperplasic Device by Application (2023-2028)
10.3 Benign Prostatic Hyperplasic Device Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Benign Prostatic Hyperplasic Device by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Benign Prostatic Hyperplasic Device by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
    Table 1. Global Benign Prostatic Hyperplasic Device Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Benign Prostatic Hyperplasic Device Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Benign Prostatic Hyperplasic Device Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Benign Prostatic Hyperplasic Device Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Benign Prostatic Hyperplasic Device Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Benign Prostatic Hyperplasic Device Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Benign Prostatic Hyperplasic Device Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Benign Prostatic Hyperplasic Device Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Benign Prostatic Hyperplasic Device Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Benign Prostatic Hyperplasic Device Manufacturing Sites and Area Served
    Table 11. Manufacturers Benign Prostatic Hyperplasic Device Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Benign Prostatic Hyperplasic Device by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Benign Prostatic Hyperplasic Device as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Benign Prostatic Hyperplasic Device Sales by Region (2017-2022) & (K Units)
    Table 16. Global Benign Prostatic Hyperplasic Device Sales Market Share by Region (2017-2022)
    Table 17. Global Benign Prostatic Hyperplasic Device Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Benign Prostatic Hyperplasic Device Revenue Market Share by Region (2017-2022)
    Table 19. North America Benign Prostatic Hyperplasic Device Sales by Country (2017-2022) & (K Units)
    Table 20. North America Benign Prostatic Hyperplasic Device Sales Market Share by Country (2017-2022)
    Table 21. North America Benign Prostatic Hyperplasic Device Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Benign Prostatic Hyperplasic Device Revenue Market Share by Country (2017-2022)
    Table 23. Europe Benign Prostatic Hyperplasic Device Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Benign Prostatic Hyperplasic Device Sales Market Share by Country (2017-2022)
    Table 25. Europe Benign Prostatic Hyperplasic Device Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Benign Prostatic Hyperplasic Device Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Benign Prostatic Hyperplasic Device Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Benign Prostatic Hyperplasic Device Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Benign Prostatic Hyperplasic Device Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Benign Prostatic Hyperplasic Device Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Benign Prostatic Hyperplasic Device Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Benign Prostatic Hyperplasic Device Sales Market Share by Country (2017-2022)
    Table 33. Latin America Benign Prostatic Hyperplasic Device Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Benign Prostatic Hyperplasic Device Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Benign Prostatic Hyperplasic Device Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Benign Prostatic Hyperplasic Device Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Benign Prostatic Hyperplasic Device Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Benign Prostatic Hyperplasic Device Revenue Market Share by Country (2017-2022)
    Table 39. Global Benign Prostatic Hyperplasic Device Sales by Type (2017-2022) & (K Units)
    Table 40. Global Benign Prostatic Hyperplasic Device Sales Market Share by Type (2017-2022)
    Table 41. Global Benign Prostatic Hyperplasic Device Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Benign Prostatic Hyperplasic Device Revenue Share by Type (2017-2022)
    Table 43. Global Benign Prostatic Hyperplasic Device Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Benign Prostatic Hyperplasic Device Sales (K Units) by Application (2017-2022)
    Table 45. Global Benign Prostatic Hyperplasic Device Sales Market Share by Application (2017-2022)
    Table 46. Global Benign Prostatic Hyperplasic Device Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Benign Prostatic Hyperplasic Device Revenue Share by Application (2017-2022)
    Table 48. Global Benign Prostatic Hyperplasic Device Price by Application (2017-2022) & (US$/Unit)
    Table 49. KARL STORZ SE Corporation Information
    Table 50. KARL STORZ SE Description and Business Overview
    Table 51. KARL STORZ SE Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. KARL STORZ SE Benign Prostatic Hyperplasic Device Product
    Table 53. KARL STORZ SE Recent Developments/Updates
    Table 54. Richard Wolf GmbH Corporation Information
    Table 55. Richard Wolf GmbH Description and Business Overview
    Table 56. Richard Wolf GmbH Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Richard Wolf GmbH Benign Prostatic Hyperplasic Device Product
    Table 58. Richard Wolf GmbH Recent Developments/Updates
    Table 59. Olympus Corporation Corporation Information
    Table 60. Olympus Corporation Description and Business Overview
    Table 61. Olympus Corporation Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Olympus Corporation Benign Prostatic Hyperplasic Device Product
    Table 63. Olympus Corporation Recent Developments/Updates
    Table 64. Urologix Corporation Information
    Table 65. Urologix Description and Business Overview
    Table 66. Urologix Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. Urologix Benign Prostatic Hyperplasic Device Product
    Table 68. Urologix Recent Developments/Updates
    Table 69. Boston Scientific Corporation Corporation Information
    Table 70. Boston Scientific Corporation Description and Business Overview
    Table 71. Boston Scientific Corporation Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. Boston Scientific Corporation Benign Prostatic Hyperplasic Device Product
    Table 73. Boston Scientific Corporation Recent Developments/Updates
    Table 74. Butterfly Corporation Information
    Table 75. Butterfly Description and Business Overview
    Table 76. Butterfly Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. Butterfly Benign Prostatic Hyperplasic Device Product
    Table 78. Butterfly Recent Developments/Updates
    Table 79. TELEFLEX Incorporated Corporation Information
    Table 80. TELEFLEX Incorporated Description and Business Overview
    Table 81. TELEFLEX Incorporated Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. TELEFLEX Incorporated Benign Prostatic Hyperplasic Device Product
    Table 83. TELEFLEX Incorporated Recent Developments/Updates
    Table 84. OmniGuide Holdings Corporation Information
    Table 85. OmniGuide Holdings Description and Business Overview
    Table 86. OmniGuide Holdings Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. OmniGuide Holdings Benign Prostatic Hyperplasic Device Product
    Table 88. OmniGuide Holdings Recent Developments/Updates
    Table 89. Convergent Laser Technologies Corporation Information
    Table 90. Convergent Laser Technologies Description and Business Overview
    Table 91. Convergent Laser Technologies Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. Convergent Laser Technologies Benign Prostatic Hyperplasic Device Product
    Table 93. Convergent Laser Technologies Recent Developments/Updates
    Table 94. ProArc Corporation Information
    Table 95. ProArc Description and Business Overview
    Table 96. ProArc Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. ProArc Benign Prostatic Hyperplasic Device Product
    Table 98. ProArc Recent Developments/Updates
    Table 99. Olympus Corporation Corporation Information
    Table 100. Olympus Corporation Description and Business Overview
    Table 101. Olympus Corporation Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. Olympus Corporation Benign Prostatic Hyperplasic Device Product
    Table 103. Olympus Corporation Recent Developments/Updates
    Table 104. Production Base and Market Concentration Rate of Raw Material
    Table 105. Key Suppliers of Raw Materials
    Table 106. Benign Prostatic Hyperplasic Device Distributors List
    Table 107. Benign Prostatic Hyperplasic Device Customers List
    Table 108. Benign Prostatic Hyperplasic Device Market Trends
    Table 109. Benign Prostatic Hyperplasic Device Market Drivers
    Table 110. Benign Prostatic Hyperplasic Device Market Challenges
    Table 111. Benign Prostatic Hyperplasic Device Market Restraints
    Table 112. Global Benign Prostatic Hyperplasic Device Sales Forecast by Type (2023-2028) & (K Units)
    Table 113. Global Benign Prostatic Hyperplasic Device Sales Market Share Forecast by Type (2023-2028)
    Table 114. Global Benign Prostatic Hyperplasic Device Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 115. Global Benign Prostatic Hyperplasic Device Revenue Market Share Forecast by Type (2023-2028)
    Table 116. Global Benign Prostatic Hyperplasic Device Sales Forecast by Application (2023-2028) & (K Units)
    Table 117. Global Benign Prostatic Hyperplasic Device Sales Market Share Forecast by Application (2023-2028)
    Table 118. Global Benign Prostatic Hyperplasic Device Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 119. Global Benign Prostatic Hyperplasic Device Revenue Market Share Forecast by Application (2023-2028)
    Table 120. Global Benign Prostatic Hyperplasic Device Sales Forecast by Region (2023-2028) & (K Units)
    Table 121. Global Benign Prostatic Hyperplasic Device Sales Market Share Forecast by Region (2023-2028)
    Table 122. Global Benign Prostatic Hyperplasic Device Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 123. Global Benign Prostatic Hyperplasic Device Revenue Market Share Forecast by Region (2023-2028)
    Table 124. Research Programs/Design for This Report
    Table 125. Key Data Information from Secondary Sources
    Table 126. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Benign Prostatic Hyperplasic Device
    Figure 2. Global Benign Prostatic Hyperplasic Device Market Share by Type in 2021 & 2028
    Figure 3. Radiofrequency Ablation Devices Product Picture
    Figure 4. Urology Lasers Devices Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Benign Prostatic Hyperplasic Device Market Share by Application in 2021 & 2028
    Figure 7. Hospitals
    Figure 8. Clinics
    Figure 9. Others
    Figure 10. Global Benign Prostatic Hyperplasic Device Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Benign Prostatic Hyperplasic Device Market Size (2017-2028) & (US$ Million)
    Figure 12. Global Benign Prostatic Hyperplasic Device Sales (2017-2028) & (K Units)
    Figure 13. Benign Prostatic Hyperplasic Device Sales Share by Manufacturers in 2021
    Figure 14. Global Benign Prostatic Hyperplasic Device Revenue Share by Manufacturers in 2021
    Figure 15. The Global 5 and 10 Largest Benign Prostatic Hyperplasic Device Players: Market Share by Revenue in 2021
    Figure 16. Benign Prostatic Hyperplasic Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 17. Global Benign Prostatic Hyperplasic Device Sales Market Share by Region (2017-2022)
    Figure 18. Global Benign Prostatic Hyperplasic Device Sales Market Share by Region in 2021
    Figure 19. Global Benign Prostatic Hyperplasic Device Revenue Market Share by Region (2017-2022)
    Figure 20. Global Benign Prostatic Hyperplasic Device Revenue Market Share by Region in 2021
    Figure 21. United States Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Canada Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Germany Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. France Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. U.K. Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Italy Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Russia Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. China Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Japan Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. South Korea Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. India Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Australia Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. China Taiwan Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Indonesia Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Thailand Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Malaysia Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Mexico Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Brazil Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Argentina Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Turkey Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Saudi Arabia Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. UAE Benign Prostatic Hyperplasic Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Sales Market Share of Benign Prostatic Hyperplasic Device by Type (2017-2022)
    Figure 44. Manufacturing Cost Structure of Benign Prostatic Hyperplasic Device
    Figure 45. Manufacturing Process Analysis of Benign Prostatic Hyperplasic Device
    Figure 46. Benign Prostatic Hyperplasic Device Industrial Chain Analysis
    Figure 47. Channels of Distribution
    Figure 48. Distributors Profiles
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Prostate Biopsy Needle Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-8J8741
Tue Apr 02 00:00:00 UTC 2024

Add to Cart

Global Castration-Resistant Prostate Cancer (CRPC) & HRPCA Therapeutics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-27S13641
Tue Apr 02 00:00:00 UTC 2024

Add to Cart

Global Prostate Biopsy Equipment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-18V7612
Wed Mar 27 00:00:00 UTC 2024

Add to Cart

Prostate Biopsy Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-35N339
Tue Mar 26 00:00:00 UTC 2024

Add to Cart